Video Experimental Relacionado

Updated: Jun 30, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Interacción cooperativa entre los proto-oncogenes c-myc y bcl-2

A Fanidi¹, E A Harrington, G I Evan

¹Biochemistry of the Cell Nucleus Laboratory, Imperial Cancer Research Fund, London, UK.

|October 8, 1992

Resumen

La proteína BCL-2 previene la apoptosis inducida por el oncogén MYC, revelando un nuevo mecanismo de cómo estos oncogenes cooperan en el desarrollo del cáncer y la resistencia a los medicamentos.

Área de la Ciencia:

Oncología Oncología.
Biología Molecular Biología Molecular
Biología celular Biología celular.

Sus antecedentes:

El proto-oncogén BCL-2 se activa en los tumores linfoides B y trabaja con el oncogén MYC en la progresión tumoral.
El papel de BCL-2 en la inhibición de la apoptosis es clave para su función, pero su sinergia con MYC no se entiende completamente.
Se sabe que MYC promueve la división celular (mitogénesis) y también induce la muerte celular programada (apoptosis).

Objetivo del estudio:

Investigar el mecanismo de sinergia entre los oncogenes BCL-2 y MYC.
Para determinar si la proteína BCL-2 puede bloquear específicamente la apoptosis inducida por MYC.
Comprender las implicaciones de esta interacción en el cáncer y la resistencia a los medicamentos.

Principales métodos:

Investigó el efecto de la expresión de la proteína BCL-2 en la apoptosis inducida por MYC.
Se evaluó si el BCL-2 afecta la función mitogénica del MYC.

Principales resultados:

La proteína BCL-2 específicamente anula la apoptosis inducida por el MYC.
BCL-2 no afecta la función mitogénica de MYC.
Esta interacción proporciona un nuevo mecanismo para la cooperación oncogénica.

Conclusiones:

Los oncogenes BCL-2 y MYC cooperan a través de la capacidad de BCL-2 para inhibir la apoptosis inducida por MYC.
Este hallazgo es significativo para la comprensión de la carcinogénesis y el desarrollo de la resistencia a los medicamentos en los tumores.
Identificó una nueva vía para la cooperación oncogénica con posibles implicaciones terapéuticas.

Más Videos Relacionados

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

Videos de Conceptos Relacionados

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

The Intrinsic Apoptotic Pathway

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...